(Q39511350)

12 September 2017

title

Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa (English)

1 reference

12 September 2017

0 references

1 reference

0 references

0 references

0 references

1 reference

John C Victor

11

0 references

Robert F Breiman

3

object named as

Robert F Breiman

Breiman, R.F.

1 reference

12 September 2017

10

Daniel R Feikin

1 reference

12 September 2017

8

Myron M Levine

1 reference

12 September 2017

12

Max Ciarlet

1 reference

12 September 2017

6

Samba O Sow

1 reference

12 September 2017

13

Kathleen M Neuzil

1 reference

12 September 2017

9

Kayla F Laserson

1 reference

12 September 2017

Milagritos D Tapia

1

1 reference

12 September 2017

George Armah

2

1 reference

12 September 2017

Michael J Dallas

4

1 reference

12 September 2017

Kristen D C Lewis

5

1 reference

12 September 2017

Stephen B Rivers

7

1 reference

12 September 2017

A Duncan Steele

14

1 reference

12 September 2017

Tapia, M.D.

0 references

Armah, G.

0 references

Dallas, M.J.

0 references

Lewis, K.D.C.

0 references

Sow, S.O.

0 references

Levine, M.M.

0 references

Laserson, K.F.

0 references

Feikin, D.R.

0 references

Victor, J.C.

0 references

Ciarlet, M.

0 references

Neuzil, K.M.

0 references

Steele, A.D.

0 references

language of work or name

English

0 references

publication date

1 April 2012

1 reference

12 September 2017

2012

0 references

published in

Vaccine

1 reference

12 September 2017

volume

30 Suppl 1

1 reference

12 September 2017

page(s)

A79-85

1 reference

http://ugspace.ug.edu.gh/handle/123456789/26883

12 September 2017

exact match

0 references

cites work

2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Efficacy of the oral pentavalent rotavirus vaccine in Mali

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Comparison of seven kits for detection of rotavirus in fecal specimens with a sensitive, specific enzyme immunoassay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Diarrhea as a Cause and an Effect of Malnutrition: Diarrhea Prevents Catch-up Growth and Malnutrition Increases Diarrhea Frequency and Duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Changing patterns of rotavirus genotypes in Ghana: Emergence of human rotavirus G9 as a major cause of diarrhea in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: Predominance of novel P[6]G8 Strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Characterization of genotype G8 strains from Malawi, Kenya, and South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Rotavirus vaccines: targeting the developing world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Genomic characterization of a novel group A lamb rotavirus isolated in Zaragoza, Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Are human P[14] rotavirus strains the result of interspecies transmissions from sheep or other ungulates that belong to the mammalian order Artiodactyla?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

Global impact of rotavirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.022

10.1016/J.VACCINE.2012.01.022

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference